PharmaRadar360
PharmaRadar360
Intelligence Layer
🇺🇸·15h agoRegulatory

FDA warns about serious problems with high doses of the allergy medicine diphenhydramine (Benadryl)

Listen to FDA Drug Safety Podcast on Drug Safety Communication titled "FDA warns about serious Probl...

Publisher

F
FDA Drug Approvals

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

Listen to FDA Drug Safety Podcast on Drug Safety Communication titled "FDA warns about serious Probl...

Source route

Continue on fda.gov

Leave the platform to read the original full article on the publisher site.

Source: FDA Drug Approvals

Scope: Regulatory

Open original article
FDA warns about serious problems with high doses of the allergy medicine diphenhydramine (Benadryl) | PharmaRadar360